Natural Product: NPC114064

Natural Product IDNPC114064
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Bisgravillol
IUPAC Name 5-[14-(3-hydroxy-5-methoxyphenyl)tetradecyl]benzene-1,3-diol
Synonyms bisgravillol
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL221393
PubChem CID 16109872
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000134] Phenols
        • [CHEMONTID:0000190] Methoxyphenols

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HACJVLBLYFAKNF-UHFFFAOYSA-N
Standard InCHI InChI=1S/C27H40O4/c1-31-27-19-23(18-26(30)21-27)15-13-11-9-7-5-3-2-4-6-8-10-12-14-22-16-24(28)20-25(29)17-22/h16-21,28-30H,2-15H2,1H3
SMILES COc1cc(CCCCCCCCCCCCCCc2cc(cc(c2)O)O)cc(c1)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   428.29 Volume:   477.777
?
Van der Waals volume.
Dense:   0.896 LogP:   7.222
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.219
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.521
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   16.0 Rigid Bonds:   12.0
TPSA:   69.92
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   3.0 Rings:   2.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.246 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.24 Fsp3:   0.556
MCE-18:   12.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.952 Fluc inhibitor:   0.414
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.383
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.641 Promiscuous compounds:   0.085

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.266 MDCK Permeability:   -4.766
Pgp-inhibitor:   0.03 Pgp-substrate:   0.003
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.003
20% Bioavailability (F20%):   0.917 30% Bioavailability (F30%):   0.975
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.025 MRP1:   0.323
Plasma Protein Binding (PPB):   99.6% Volume Distribution (VD):   1.411
Fu: 0.718%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.996
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.939
BSEP inhibitor:   0.943

ADMET: Metabolism

CYP1A2-inhibitor:   0.998 CYP1A2-substrate:   0.999
CYP2C19-inhibitor:   0.998 CYP2C19-substrate:   0.995
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   1.0
CYP2D6-inhibitor:   0.999 CYP2D6-substrate:   0.999
CYP3A4-inhibitor:   0.033 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.139 CYP2C8-inhibitor:   1.0
HLM stability:   0.983
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.141 Half-life (T1/2):  1.685

ADMET: Toxicity

hERG Blockers:  0.841 hERG Blockers (10um):  0.922
Human Hepatotoxicity (H-HT):  0.565 Drug-induced Liver Injury (DILI):  0.105
AMES Toxicity:  0.146 Rat Oral Acute Toxicity:  0.168
Maximum Recommended Daily Dose:  0.763 Skin Sensitization:  0.982
Carcinogencity:  0.23 Eye Corrosion:  0.498
Eye Irritation:  0.996 Respiratory Toxicity:  0.923
Drug-induced Neurotoxicity:  0.103 Ototoxicity:  0.176
Hematotoxicity:  0.058 Drug-induced Nephrotoxicity:  0.121
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.068
A549 Cytotoxicity:  0.901 Hek293 Cytotoxicity:  0.908
BCF:   1.384
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.396
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.525
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.527
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8945 Grevillea robusta Species Proteaceae Eukaryota leaves n.a. n.a. PMID[17243726]
NPO8945 Grevillea robusta Species Proteaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8945 Grevillea robusta Species Proteaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8945 Grevillea robusta Species Proteaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8945 Grevillea robusta Species Proteaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO8945 Grevillea robusta Species Proteaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell line MCF7 Homo sapiens IC50 = 29400.0 nM PMID[20584605]
NPT397 Cell line NCI-H460 Homo sapiens IC50 = 28700.0 nM PMID[26396683]
NPT395 Cell line SF-268 Homo sapiens IC50 = 29400.0 nM PMID[21733687]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC114064 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8605 High Similarity NPC127894
0.8605 High Similarity NPC470759
0.7949 Intermediate Similarity NPC168657
0.7674 Intermediate Similarity NPC219070
0.7021 Intermediate Similarity NPC15860
0.6818 Remote Similarity NPC78446
0.68 Remote Similarity NPC140521
0.6486 Remote Similarity NPC246056
0.6 Remote Similarity NPC294186
0.6 Remote Similarity NPC147310
0.6 Remote Similarity NPC249836
0.6 Remote Similarity NPC137415
0.6 Remote Similarity NPC166313
0.6 Remote Similarity NPC192032
0.6 Remote Similarity NPC24407
0.6 Remote Similarity NPC11280
0.5714 Remote Similarity NPC29577
0.5581 Remote Similarity NPC470700
0.5581 Remote Similarity NPC54844
0.5581 Remote Similarity NPC39097
0.5581 Remote Similarity NPC302681
0.5581 Remote Similarity NPC241891
0.5581 Remote Similarity NPC118286
0.5581 Remote Similarity NPC134829
0.5581 Remote Similarity NPC109691
0.551 Remote Similarity NPC181361
0.5455 Remote Similarity NPC603370
0.5333 Remote Similarity NPC53051
0.5333 Remote Similarity NPC24404
0.5333 Remote Similarity NPC313030
0.5333 Remote Similarity NPC39664
0.5294 Remote Similarity NPC82299
0.5217 Remote Similarity NPC146798
0.5217 Remote Similarity NPC222522
0.5217 Remote Similarity NPC106396
0.5217 Remote Similarity NPC276737
0.5217 Remote Similarity NPC141090
0.5217 Remote Similarity NPC94351
0.5217 Remote Similarity NPC168303
0.5208 Remote Similarity NPC135414
0.5106 Remote Similarity NPC22610
0.5106 Remote Similarity NPC486908

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC114064 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data